As of early 2026, the geographic distribution of non-invasive liver diagnostic technology is undergoing a significant transformation. According to the latest Fibroscan Market region data, North America continues to hold the largest share of the global market, currently estimated at 35%. This dominance is supported by a sophisticated healthcare infrastructure, high awareness of Metabolic...